Ignite Creation Date:
2025-12-24 @ 11:17 PM
Ignite Modification Date:
2025-12-25 @ 8:56 PM
Study NCT ID:
NCT02242656
Status:
WITHDRAWN
Last Update Posted:
2015-02-18
First Post:
2014-09-10
Is NOT Gene Therapy:
False
Has Adverse Events:
False
Brief Title:
A Phase III Study to Evaluate the Efficacy, Safety, and Pharmacokinetics of Investigational Product MP-101 in Subjects With Short Bowel Syndrome Who Have Had an Inadequate Response to Anti-Diarrheals
Sponsor:
Marathon Pharmaceuticals, LLC
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2014-12
Start Date Type:
None
Primary Completion Date:
2017-12
Primary Completion Date Type:
ESTIMATED
Completion Date:
None
Completion Date Type:
None
First Submit Date:
2014-09-10
First Submit QC Date:
None
Study First Post Date:
2014-09-17
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2015-02-16
Last Update Post Date:
2015-02-18
Last Update Post Date Type:
ESTIMATED